479 related articles for article (PubMed ID: 7575435)
1. Induction of Ca2+/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms.
Spence S; Rena G; Sweeney G; Houslay MD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):975-82. PubMed ID: 7575435
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase.
Spence S; Rena G; Sullivan M; Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):157-63. PubMed ID: 9003415
[TBL] [Abstract][Full Text] [Related]
3. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
4. Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction.
Geoffroy V; Fouque F; Nivet V; Clot JP; Lugnier C; Desbuquois B; Benelli C
Eur J Biochem; 1999 Feb; 259(3):892-900. PubMed ID: 10092879
[TBL] [Abstract][Full Text] [Related]
5. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
Bian JS; Zhang WM; Pei JM; Wong TM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
Michie AM; Rena G; Harnett MM; Houslay MD
Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
[TBL] [Abstract][Full Text] [Related]
8. Activity of cyclic AMP phosphodiesterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries.
Walikonis RS; Poduslo JF
J Biol Chem; 1998 Apr; 273(15):9070-7. PubMed ID: 9535895
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1).
Kakkar R; Raju RV; Sharma RK
Cell Mol Life Sci; 1999 Jul; 55(8-9):1164-86. PubMed ID: 10442095
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
Yu H; Cai JJ; Lee HC
Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
[TBL] [Abstract][Full Text] [Related]
11. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene.
Li H; Oehrlein SA; Wallerath T; Ihrig-Biedert I; Wohlfart P; Ulshöfer T; Jessen T; Herget T; Förstermann U; Kleinert H
Mol Pharmacol; 1998 Apr; 53(4):630-7. PubMed ID: 9547352
[TBL] [Abstract][Full Text] [Related]
12. The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner.
Yan C; Zhao AZ; Bentley JK; Beavo JA
J Biol Chem; 1996 Oct; 271(41):25699-706. PubMed ID: 8810348
[TBL] [Abstract][Full Text] [Related]
13. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.
Jiang X; Li J; Paskind M; Epstein PM
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11236-41. PubMed ID: 8855339
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotide to PKC-epsilon alters cAMP-dependent stimulation of CFTR in Calu-3 cells.
Liedtke CM; Cole TS
Am J Physiol; 1998 Nov; 275(5):C1357-64. PubMed ID: 9814985
[TBL] [Abstract][Full Text] [Related]
16. Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11.
Ahmad M; Abdel-Wahab YH; Tate R; Flatt PR; Pyne NJ; Furman BL
Br J Pharmacol; 2000 Mar; 129(6):1228-34. PubMed ID: 10725272
[TBL] [Abstract][Full Text] [Related]
17. Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle.
Bloom TJ
Can J Physiol Pharmacol; 2002 Dec; 80(12):1132-5. PubMed ID: 12564638
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
Kostic MM; Erdogan S; Rena G; Borchert G; Hoch B; Bartel S; Scotland G; Huston E; Houslay MD; Krause EG
J Mol Cell Cardiol; 1997 Nov; 29(11):3135-46. PubMed ID: 9405187
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
